CAS Registry Services℠

Patentes CAS

Nuestra recopilación de patentes se complementa con títulos y resúmenes en inglés y con una indexación detallada realizada por científicos del CAS, lo que permite buscar y acceder a aspectos complejos de los documentos de patentes, incluidas las sustancias químicas, las secuencias, las estructuras de Markush, los cesionarios y los códigos de clasificación.

Contacto con nosotros
Hexagon shaped overlay
Glowing blue technical blueprint of a circular mechanical part with measurements and circuit-like background.

Características

Patents published by 109 issuing authorities covering more than 40,000 unique IPC codes in areas including chemistry, pharmaceuticals, consumer goods, processes, materials, engineering, agriculture, and more.

English language titles and abstracts for patents published in 50 languages translated and enhanced by CAS scientists.

Key invention details including substances, reactions, Markush representations, and more indexed by scientists and connected to other relevant data within the CAS Content Collection™.

Consolidated patent family summaries and convenient connections to global full-text patent documents.

Claims text, legal status information, cited references, and examiner citations included for select authorities.

Updated daily, with patent applications from nine major patent issuing authorities available within two days of publication.

Latest from CAS Insights™

Drug Discovery

AI in drug discovery: Moving from potential to practical

CAS hosted Life Sciences Summits across three regions in 2025, exploring practical AI integration in drug discovery. Learn about data governance, implementation barriers, and modality-specific challenges.
|Article
Ciencia emergente

Nipah virus explained: Risks, realities, and the hope from new research

New Nipah cases in India have renewed focus on a high‑fatality zoonotic threat shaped by complex spillover dynamics, severe neurological disease, and limited medical countermeasures. Meanwhile, global efforts in diagonistcs, therapeutics, and vaccines are accelerating.
|Article
Biotechnology

Innovaciones en la inmunoterapia del cáncer: los captadores biespecíficos de células T

Los activadores biespecíficos de las células T están a punto de convertirse en tratamientos de inmunoterapia clave debido a la simplificación de la producción y a los nuevos avances de seguridad.
|Article